article thumbnail

Intoxicating Hemp Swindle

Project CBD

These can include Delta-8 and Delta-9 THC, which are typically synthesized from CBD isolate that’s sourced from hemp. There’s also THCP, THCO, HHC, and others that can’t be made from CBD starter material and thus are outside the legal definition of “hemp.” Devitt expresses serious safety concerns.

Hemp 230
article thumbnail

Clinical Study: CBD Effect on the Liver in Adults

Project CBD

Project CBD seeks volunteers to assess the safety and efficacy of cannabidiol.

CBD 299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Discover CBD got ahead in CBD safety

Leafly

DiscoverCBD got ahead of the CBD surge by keeping consumer safety in the forefront. The post How Discover CBD got ahead in CBD safety appeared first on Leafly. The spontaneous nature of the cannabis industry is hard to predict.

Safety 138
article thumbnail

Expanded Clinical Study: CBD Effect on the Liver in Adults

Project CBD

Last summer, Project CBD helped recruit subjects for a large-scale clinical study to assess the safety and efficacy of the daily use of cannabidiol. Good news: Contrary to FDA warnings, preliminary results of the ValidCare study show “no clinical evidence of liver disease in any of the participants.”

CBD 288
article thumbnail

Landmark CBD Study Concludes: No Liver Toxicity with CBD Use

Cannabis Cheri

Care by Design Hemp , a wholly-owned CannaCraft brand, is pleased to announce that the groundbreaking clinical study exploring the effects of CBD on liver health has concluded after seven months of research. The results showed the study’s participants exhibited no evidence of liver toxicity after using CBD daily for a minimum of 60 days.

CBD 235
article thumbnail

FDA Hearing On ‘Hemp-Derived CBD’ Today

NORML

Washington, DC : Today the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. ” Currently, commercially marketed CBD-infused products are not subject to explicit federal regulations. .”

Hemp 223
article thumbnail

NORML Submits Comments to FDA Ahead of CBD Hearing

NORML

NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. Currently, commercially marketed CBD-infused products are not subject to explicit federal regulations.

CBD 223